Carmichael Hill & Associates’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-60
Closed -$1.35K 780
2024
Q2
$1.35K Hold
60
﹤0.01% 716
2024
Q1
$1.58K Hold
60
﹤0.01% 698
2023
Q4
$1.89K Hold
60
﹤0.01% 712
2023
Q3
$1.68K Hold
60
﹤0.01% 708
2023
Q2
$2.21K Hold
60
﹤0.01% 694
2023
Q1
$1.8K Hold
60
﹤0.01% 700
2022
Q4
$1.84K Sell
60
-60
-50% -$1.8K ﹤0.01% 693
2022
Q3
$3K Buy
120
+60
+100% +$1.98K ﹤0.01% 712
2022
Q2
$2K Hold
60
﹤0.01% 718
2022
Q1
$2K Sell
60
-3
-5% -$94 ﹤0.01% 741
2021
Q4
$2K Hold
63
﹤0.01% 754
2021
Q3
$2K Hold
63
﹤0.01% 741
2021
Q2
$2K Hold
63
﹤0.01% 723
2021
Q1
$2K Hold
63
﹤0.01% 705
2020
Q4
$2K Hold
63
﹤0.01% 683
2020
Q3
$1K Hold
63
﹤0.01% 676
2020
Q2
$1K Hold
63
﹤0.01% 649
2020
Q1
$1K Sell
63
-40
-39% -$577 ﹤0.01% 636
2019
Q4
$2K Buy
+103
New +$1.71K ﹤0.01% 617

Other funds holding CC

Carmichael Hill & Associates's CC Position: Q3 2024 in Review

Carmichael Hill & Associates sold out of Chemours (CC) in Q3 2024, closing a stake of 60 shares — an estimated $1.35K sold.

Carmichael Hill & Associates first reported a position in CC in Q4 2019 and held it in 19 quarters. The position peaked at $3K in Q3 2022. 421 funds tracked by Wall St. Rank hold CC as of Q3 2024.

  • Carmichael Hill & Associates reported no remaining Chemours position as of Q3 2024 after selling out during the quarter.
  • Carmichael Hill & Associates sold 60 Chemours shares in Q3 2024, an estimated $1.35K.
  • Carmichael Hill & Associates first reported a position in Chemours in Q4 2019 and held it in 19 quarters.
  • Carmichael Hill & Associates's Chemours position peaked at $3K in Q3 2022.
  • 421 funds tracked by Wall St. Rank held Chemours as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.